It shouldn't affect the share price. As indicated in the CEO tweets posted last night, Gerald was informed of the continued sale of T-Cell Protect products bearing the Todos logo and 3CL protease inhibitor claims, which was not supposed to be occurring since they had previously terminated their agreement. Kudos to the company for taking very swift actions to remedy this.
News 
Market Data 
Discover 
AI
